DuChemBIO Co.,Ltd. (KOSDAQ:176750)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,060.00
+20.00 (0.22%)
At close: Apr 27, 2026
-19.75%
Market Cap 255.39B
Revenue (ttm) 38.57B
Net Income (ttm) 6.48B
Shares Out 28.34M
EPS (ttm) 228.00
PE Ratio 39.52
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,254
Average Volume 26,798
Open 9,100.00
Previous Close 9,040.00
Day's Range 8,980.00 - 9,110.00
52-Week Range 8,360.00 - 12,770.00
Beta 0.18
RSI 45.02
Earnings Date May 13, 2026

About DuChemBIO

DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea. Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amylo... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2002
Employees 126
Stock Exchange KOSDAQ
Ticker Symbol 176750
Full Company Profile

Financial Performance

In 2025, DuChemBIO's revenue was 38.57 billion, an increase of 8.35% compared to the previous year's 35.60 billion. Earnings were 6.48 billion, a decrease of -18.94%.

Financial Statements

News

There is no news available yet.